Association between small dense low-density lipoprotein cholesterol and neuroimaging markers of cerebral small vessel disease in middle-aged and elderly Chinese populations

Table 3 The logistic regression analysis of LDL subtype for patients with and without CSVD

Variables	β	Wals	OR (95%CI)	P value
LDL-C1	0.033	5.934	1.03(1.01–1.06)	0.015
LDL-C2	−0.056	4.393	0.95(0.90–1.00)	0.036
LDL-C3	0.198	10.040	1.22(1.08–1.38)	0.002
LDL-C4	−0.088	0.792	0.92(0.75–1.11)	0.373
LDL-C5	0.291	3.736	1.34(1.00–1.80)	0.053
LDL-C6	−0.114	0.121	0.89(0.47–1.70)	0.728
LDL-C7	0.015	0.002	1.02(0.54–1.92)	0.964
Gender	−0.471	4.069	0.62(0.40–0.99)	0.044
Age	0.047	12.885	1.05(1.02–1.08)	0.000
Pulse pressure	0.008	1.904	1.01(1.00–1.02)	0.168
Hypertension	0.714	8.377	2.04(1.26–3.31)	0.004
Previous ischemic stroke	0.785	7.436	2.19(1.25–3.86)	0.006
Diabetes	0.469	2.138	1.60(0.85–3.00)	0.144
Statin therapy	−0.263	1.242	0.77(0.48–1.22)	0.265

Model 2 adjust for LDL subtypes, Gender, Age, Pulse pressure, Hypertension, Previous ischemic stroke, Diabetes and Statin therapy
OR odds ratio, CI confidence interval